These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 5472233)

  • 1. [Our experience with Daonil. A new oral hypoglycemic agent].
    Rodriguez-Miñon JL; Arrieta F; Herrera JL
    Diabete; 1970; 18(3):164-5. PubMed ID: 5472233
    [No Abstract]   [Full Text] [Related]  

  • 2. [Glybenclamide and its place among sulfanylureas in the treatment of diabetes mellitus].
    Cabezas Cerrato J; Fernández-Cruz A; Fernández-Cruz A
    Rev Clin Esp; 1970 May; 117(4):375-86. PubMed ID: 5471527
    [No Abstract]   [Full Text] [Related]  

  • 3. [Progress in diabetes therapy using glibenclamide and phenformin. Report from the years 1967-1970 on 323 patients].
    Beyer J; Ewald W; Kunkel W; Wolf E; Schöffling K
    Dtsch Med Wochenschr; 1971 Apr; 96(17):728-33. PubMed ID: 5552854
    [No Abstract]   [Full Text] [Related]  

  • 4. Glibenclamide in the management of diabetes mellitus. I.
    Devlin JG; Manning K; Harty J
    J Ir Med Assoc; 1971 Apr; 64(409):197-9. PubMed ID: 5554337
    [No Abstract]   [Full Text] [Related]  

  • 5. [Preliminary results with a new oral antidiabetic drug of the sulfanylurea series: glibenclamide or HB 419].
    Marocco F; Patrito G
    Minerva Med; 1970 Dec; 61(97):5525-42. PubMed ID: 5494124
    [No Abstract]   [Full Text] [Related]  

  • 6. [The development of sulfonylurea late resistance].
    Angeli I
    Med Klin; 1970 Feb; 65(7):306-9. PubMed ID: 4996930
    [No Abstract]   [Full Text] [Related]  

  • 7. [Oral differential therapy of diabetes mellitus].
    Mehnert H
    Dtsch Med Wochenschr; 1970 Aug; 95(35):1795-6. PubMed ID: 5451987
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical experience with glybenclamide in 100 non-ketotic diabetics.
    Sahgal VK; Ahuja MM
    Indian J Med Res; 1971 Feb; 59(2):251-8. PubMed ID: 4931412
    [No Abstract]   [Full Text] [Related]  

  • 9. [Personal experience on the use of glybenclamide (a new oral hypoglycemic agent)].
    Rodríguez-Miñón JL; Arrieta F; Herrera JL
    Rev Clin Esp; 1970 May; 117(4):371-4. PubMed ID: 5471526
    [No Abstract]   [Full Text] [Related]  

  • 10. [Oral treatment of diabetes mellitus with the new sulfonylurea tolazamide].
    Vogel G; Krummel E
    Arzneimittelforschung; 1969 Jul; 19(7):1128-30. PubMed ID: 5394514
    [No Abstract]   [Full Text] [Related]  

  • 11. A controlled clinical trial of a new oral hypoglycemic agent, glipizide (K 4024).
    Lentini S; Bossini A; Pirola LC
    Arzneimittelforschung; 1972 Jul; 22(7):1169-73. PubMed ID: 4678124
    [No Abstract]   [Full Text] [Related]  

  • 12. Tolazamide in the treatment of diabetes mellitus: clinical experience and review of the literature.
    Balodimos MC; Marble A
    Curr Ther Res Clin Exp; 1971 Jan; 13(1):6-12. PubMed ID: 4992570
    [No Abstract]   [Full Text] [Related]  

  • 13. Experience with phenformin as an oral antidiabetic agent.
    Drury MI; Timoney FJ
    J Ir Med Assoc; 1970 Jan; 63(391):13-7. PubMed ID: 4903812
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical and metabolic observations with a new synthetic oral antidiabetic agent, glipizide.
    D'Onofrio F; Pempinello R; Romis L
    Arzneimittelforschung; 1972 Nov; 22(11):1879-81. PubMed ID: 4679059
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical experience concerning the action of a new oral antidiabetic drug: glidiazinamide].
    Greco AV; Fedeli G; Ghirlanda G; Lucente M; Accietto F; Fenici R
    Minerva Med; 1971 Jul; 62(57):2829-39. PubMed ID: 5565179
    [No Abstract]   [Full Text] [Related]  

  • 16. Glipizide, a new sulfonylurea in the treatment of diabetes mellitus. Summary of clinical experience in 1064 cases.
    Emanueli A; Molari E; Pirola LC; Caputo G
    Arzneimittelforschung; 1972 Nov; 22(11):1881-5. PubMed ID: 4267009
    [No Abstract]   [Full Text] [Related]  

  • 17. [Results of oral therapy of diabetes mellitus with the new sulfonylurea tolazamide under ambulatory conditions].
    Düntsch G
    Arzneimittelforschung; 1970 Apr; 20(4):577-9. PubMed ID: 5467825
    [No Abstract]   [Full Text] [Related]  

  • 18. [Results of oral therapy of diabetes mellitus with the new sulfonylurea tolazamide under ambulatory conditions].
    Düntsch G
    Arzneimittelforschung; 1970 Apr; 20(4):575-9. PubMed ID: 5467824
    [No Abstract]   [Full Text] [Related]  

  • 19. A clinical trial of glybenclamide (HB-419): a new oral hypoglycemic agent.
    Choudhry AS; Gomez E; McKendry JB
    Appl Ther; 1970 May; 12(5):28-9. PubMed ID: 4912481
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical evaluation of Daonil--a new sulphonylurea derivative].
    Nowotna-Walcowa R; Rozyńska E
    Pol Tyg Lek; 1971 Jan; 26(2):65-7. PubMed ID: 5101252
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.